Clinical Trial Update: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled trial evaluating brivaracetam for neuropathic pain in chronic spinal cord injury has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Briviact (brivaracetam)

Snippet

Sponsor: University of Minnesota | Conditions: Spinal Cord Injuries, Neuropathic Pain | Phase 3 | Status: COMPLETED | Results posted: 2026-03-18